Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2013

01-12-2013 | Short Research Report

Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia

Authors: Jian Lynn Lee, Adyani Md Redzuan, Noraida Mohamed Shah

Published in: International Journal of Clinical Pharmacy | Issue 6/2013

Login to get access

Abstract

Background Unlicensed and off-label use of medicines in paediatrics is widespread. However, the incidence of this practice in Malaysia has not been reported. Objective To determine the extent of unlicensed and off-label use of medicines in hospitalised children in the intensive care units of a tertiary care teaching hospital. Methods A prospective, observational exploratory study was conducted on medicines prescribed to children admitted to the 3 intensive care units of Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Results A total of 194 patients were admitted to UKMMC, 168 of them received one or more drugs. Of 1,295 prescriptions, 353 (27.3 %) were unlicensed and 442 (34.1 %) were for off-label use. Forty-four percent of patients received at least one medicine for unlicensed use and 82.1 % received at least one medicine off-label. Preterm infants, children aged 28 days to 23 months, patients with hospital stays of more than 2 weeks, and those prescribed increasing numbers of medicines were more likely to receive medicines for unlicensed use. Term neonates and patients prescribed increasing numbers of medicines had increased risk of receiving medicines for off-label use. Conclusion Prescribing of medicines in an unlicensed or off-label fashion to the children in the intensive care units of UKMMC was common. Further detailed studies are necessary to ensure the delivery of safe and effective medicines to children.
Literature
1.
go back to reference Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343–5.PubMedCrossRef Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998;316:343–5.PubMedCrossRef
2.
go back to reference Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med. 1960;262:787–94.PubMedCrossRef Weiss CF, Glazko AJ, Weston JK. Chloramphenicol in the newborn infant. N Engl J Med. 1960;262:787–94.PubMedCrossRef
3.
go back to reference Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18(4):614–25.PubMed Silverman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics. 1956;18(4):614–25.PubMed
4.
go back to reference Gazarian M. Why are children still therapeutic orphans? Aust Prescr. 2003;26(6):122–3. Gazarian M. Why are children still therapeutic orphans? Aust Prescr. 2003;26(6):122–3.
5.
go back to reference Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.PubMedCrossRef Shah SS, Hall M, Goodman DM, et al. Off-label drug use in hospitalized children. Arch Pediatr Adolesc Med. 2007;161:282–90.PubMedCrossRef
6.
go back to reference Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F142–5.PubMedCrossRef Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;80:F142–5.PubMedCrossRef
7.
go back to reference ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJM, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children’s Hospital. Pediatrics. 2001;108(5):1089–93.PubMedCrossRef ‘t Jong GW, Vulto AG, de Hoog M, Schimmel KJM, Tibboel D, van den Anker JN. A survey of the use of off-label and unlicensed drugs in a Dutch Children’s Hospital. Pediatrics. 2001;108(5):1089–93.PubMedCrossRef
8.
go back to reference Bajcetic M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775–9.PubMedCrossRef Bajcetic M, Jelisavcic M, Mitrovic J, et al. Off label and unlicensed drugs use in paediatric cardiology. Eur J Clin Pharmacol. 2005;61:775–9.PubMedCrossRef
9.
go back to reference Dessi A, Salemi C, Fanos V, Cuzzolin L. Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci. 2010;32:120–4.PubMedCrossRef Dessi A, Salemi C, Fanos V, Cuzzolin L. Drug treatments in a neonatal setting: focus on the off-label use in the first month of life. Pharm World Sci. 2010;32:120–4.PubMedCrossRef
10.
go back to reference Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilization pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(12):1263–71.PubMedCrossRef Lass J, Kaar R, Jogi K, Varendi H, Metsvaht T, Lutsar I. Drug utilization pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol. 2011;67(12):1263–71.PubMedCrossRef
11.
go back to reference Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a pediatric intensive care unit. Indian J Pediatr. 2009;76:1113–8.PubMedCrossRef Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain SS, Jadhav S. Off-label drug use in a pediatric intensive care unit. Indian J Pediatr. 2009;76:1113–8.PubMedCrossRef
12.
go back to reference O’Donnelle CPF, Stone RJ, Morley C. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002;110(5):e52.CrossRef O’Donnelle CPF, Stone RJ, Morley C. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics. 2002;110(5):e52.CrossRef
13.
go back to reference Khdour MR, Hallak HO, Alayasa KSA, AlShahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011;33(4):650–5.PubMedCrossRef Khdour MR, Hallak HO, Alayasa KSA, AlShahed QN, Hawwa AF, McElnay JC. Extent and nature of unlicensed and off-label medicine use in hospitalised children in Palestine. Int J Clin Pharm. 2011;33(4):650–5.PubMedCrossRef
16.
go back to reference Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J. Preparation of medicines for children—a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.PubMedCrossRef Ernest TB, Craig J, Nunn A, Salunke S, Tuleu C, Breitkreutz J, Alex R, Hempenstall J. Preparation of medicines for children—a hierarchy of classification. Int J Pharm. 2012;435(2):124–30.PubMedCrossRef
Metadata
Title
Unlicensed and off-label use of medicines in children admitted to the intensive care units of a hospital in Malaysia
Authors
Jian Lynn Lee
Adyani Md Redzuan
Noraida Mohamed Shah
Publication date
01-12-2013
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2013
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-013-9846-0

Other articles of this Issue 6/2013

International Journal of Clinical Pharmacy 6/2013 Go to the issue